Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5101
Greenland Energy Co
GLND
$105M
| $10 | ﹤0.01% |
+2
| New | +$4 |
2026 Q3
0 quarters
|
|
5102
AIAI Holdings
AIAI
$64.7M
| $10 | ﹤0.01% |
3
-1,630
| -100% | -$9.3K |
2026 Q2
1 quarter
|
|
5103
Ashford Hospitality Trust
AHT
$15.3M
| $9 | ﹤0.01% |
4
-41
| -91% | -$127 |
2026 Q2
1 quarter
|
|
5104
Streamex Corp
STEX
$39.5M
| $9 | ﹤0.01% |
+14
| New | +$11 |
2026 Q3
0 quarters
|
|
5105
Dominari Holdings
DOMH
$33.9M
| $9 | ﹤0.01% |
4
-911
| -100% | -$2.32K |
2026 Q2
1 quarter
|
|
5106
Goldman Sachs BDC
GSBD
$973M
| $9 | ﹤0.01% |
+1
| New | +$9 |
2026 Q3
0 quarters
|
|
5107
T Stamp
IDAI
$12.8M
| $9 | ﹤0.01% |
3
-98
| -97% | -$268 |
2026 Q2
1 quarter
|
|
5108
MDxHealth
MDXH
$15M
| $9 | ﹤0.01% |
16
| – | – |
2025 Q3
4 quarters
|
|
5109
Metalla Royalty & Streaming
MTA
$756M
| $9 | ﹤0.01% |
+1
| New | +$9 |
2026 Q3
0 quarters
|
|
5110
Palatin Technologies
PTN
$11.2M
| $9 | ﹤0.01% |
1
-9
| -90% | -$88 |
2026 Q2
1 quarter
|
|
5111
Siebert Financial
SIEB
$73.4M
| $9 | ﹤0.01% |
4
-650
| -99% | -$1.28K |
2025 Q2
5 quarters
|
|
5112
SkinHealth Systems
SKIN
$102M
| $9 | ﹤0.01% |
1
-345
| -100% | -$4.95K |
2022 Q1
18 quarters
|
|
5113
Safe Pro Group Inc
SPAI
$64.8M
| $9 | ﹤0.01% |
2
-27
| -93% | -$120 |
2025 Q4
3 quarters
|
|
5114
Key Tronic
KTCC
$14.6M
| $8 | ﹤0.01% |
4
-37
| -90% | -$125 |
2026 Q2
1 quarter
|
|
5115
DELISTED
Sleep Number
SNBR
| $8 | ﹤0.01% |
401
-30
| -7% | -$1 |
2013 Q2
53 quarters
|
|
5116
WidePoint Corp
WYY
$62.9M
| $8 | ﹤0.01% |
+1
| New | +$11 |
2026 Q3
0 quarters
|
|
5117
NextTrip
NTRP
$16.9M
| $8 | ﹤0.01% |
4
-45
| -92% | -$76 |
2026 Q2
1 quarter
|
|
5118
Serina Therapeutics
SER
$35.1M
| $8 | ﹤0.01% |
4
-541
| -99% | -$1.26K |
2026 Q2
1 quarter
|
|
5119
Apyx Medical
APYX
$123M
| $7 | ﹤0.01% |
3
-349
| -99% | -$1.22K |
2026 Q1
2 quarters
|
|
5120
LeonaBio Inc
LONA
$41.6M
| $7 | ﹤0.01% |
2
-40
| -95% | -$296 |
2026 Q2
1 quarter
|
|
5121
Drilling Tools International
DTI
$50.5M
| $7 | ﹤0.01% |
+3
| New | +$7 |
2026 Q3
0 quarters
|
|
5122
GoodRx Holdings
GDRX
$1.2B
| $7 | ﹤0.01% |
2
-191,654
| -100% | -$638K |
2022 Q1
18 quarters
|
|
5123
Ispire Technology
ISPR
$89.5M
| $7 | ﹤0.01% |
5
-937
| -99% | -$1.4K |
2023 Q2
13 quarters
|
|
5124
LENSAR
LNSR
$67M
| $7 | ﹤0.01% |
1
-456
| -100% | -$3.15K |
2025 Q2
5 quarters
|
|
5125
Microbot Medical
MBOT
$74.6M
| $7 | ﹤0.01% |
6
-52
| -90% | -$84 |
2015 Q4
43 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.